Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Boston Scientific Corp (NYSE: BSX) closed at $100.04 down -2.01% from its previous closing price of $102.09. In other words, the price has decreased by -$2.01 from its previous closing price. On the day, 8.48 million shares were traded. BSX stock price reached its highest trading level at $101.51 during the session, while it also had its lowest trading level at $99.62.
Ratios:
For a deeper understanding of Boston Scientific Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 178.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 49.11. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 1.45. In the meantime, Its Debt-to-Equity ratio is 0.53 whereas as Long-Term Debt/Eq ratio is at 0.49.
On January 10, 2025, Deutsche Bank Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $108.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 04 ’25 when Fitzgerald Joseph Michael sold 56,372 shares for $102.88 per share. The transaction valued at 5,799,630 led to the insider holds 178,342 shares of the business.
JOSEPH M FITZGERALD bought 56,372 shares of BSX for $5,799,625 on Jun 04 ’25. On Jun 02 ’25, another insider, Mahoney Michael F, who serves as the Chairman, President & CEO of the company, sold 164,443 shares for $103.69 each. As a result, the insider received 17,051,136 and left with 1,476,882 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BSX now has a Market Capitalization of 151036395520 and an Enterprise Value of 159219810304. As of this moment, Boston’s Price-to-Earnings (P/E) ratio for their current fiscal year is 73.30, and their Forward P/E ratio for the next fiscal year is 30.37. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.24. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.43 while its Price-to-Book (P/B) ratio in mrq is 6.66. Its current Enterprise Value per Revenue stands at 9.07 whereas that against EBITDA is 35.101.
Stock Price History:
The Beta on a monthly basis for BSX is 0.69, which has changed by 0.29669476 over the last 52 weeks, in comparison to a change of 0.11730647 over the same period for the S&P500. Over the past 52 weeks, BSX has reached a high of $107.17, while it has fallen to a 52-week low of $71.88. The 50-Day Moving Average of the stock is -0.78%, while the 200-Day Moving Average is calculated to be 6.34%.
Shares Statistics:
For the past three months, BSX has traded an average of 8.33M shares per day and 7596310 over the past ten days. A total of 1.48B shares are outstanding, with a floating share count of 1.47B. Insiders hold about 0.40% of the company’s shares, while institutions hold 92.18% stake in the company. Shares short for BSX as of 1747267200 were 16752863 with a Short Ratio of 2.01, compared to 1744675200 on 14494253. Therefore, it implies a Short% of Shares Outstanding of 16752863 and a Short% of Float of 1.13.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
